Viewing Study NCT00239161



Ignite Creation Date: 2024-05-05 @ 12:04 PM
Last Modification Date: 2024-10-26 @ 9:20 AM
Study NCT ID: NCT00239161
Status: TERMINATED
Last Update Posted: 2005-10-14
First Post: 2005-10-12

Brief Title: Safety and Efficacy Study of the Treatment of Kidney Infections With Short Course Levofloxacin
Sponsor: University of Manitoba
Organization: University of Manitoba

Study Overview

Official Title: TREATMENT OF ACUTE UNCOMPLICATED PYELONEPHRITIS WITH SHORT COURSE LEVOFLOXACIN A Pilot Study
Status: TERMINATED
Status Verified Date: 2005-08
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of the study is to compare the safety and effectiveness of the antibiotic levofloxacin by administering a higher dose of levofloxacin using a shorter course of therapy to treat patients with infections of their kidney
Detailed Description: The goal is to complete a pilot study of short course 5 days high dose levofloxacin treatment for women with acute uncomplicated pyelonephritis Specific study objectives include

1 To assess the efficacy and tolerability of levofloxacin 750 mg once daily for treatment of acute uncomplicated pyelonephritis in 25 women
2 To describe the population pharmacokinetics of levofloxacin 750 mg once daily in treatment of young women with acute pyelonephritis
3 To identify urine proteins associated with the inflammatory response of acute pyelonephritis and characterize the time course of resolution of these proteins following initiation of treatment

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None
Secondary IDs
Secondary ID Type Domain Link
LOF-UTI-2 None None None